Gaurav Kaul has been appointed Managing Director and Chief Executive Officer of Cipla Health, effective October 2026. He takes on the new leadership role after spending over five years with Cipla, where he most recently served as Chief Commercial Head – Rx, India Business.
In his previous role, Kaul led Cipla’s commercial operations in India across acute and chronic therapies, overseeing a business valued at over ₹15,000 crore and an organisation comprising more than 12,000 employees. During his tenure, he also served as Chief Commercial Head – Respiratory, where he managed the category’s profit and loss responsibilities. Under his leadership, Cipla’s respiratory portfolio maintained its position as the leading portfolio in the Indian Pharmaceutical Market, alongside initiatives focused on patient engagement and consumer campaigns.
Before joining Cipla, Kaul spent nearly eight years with GSK Consumer Healthcare India, where he held several leadership positions, including General Manager – West and East and General Manager – Pharmacy. He also served as Head of Sales for India and Sri Lanka at Novartis Consumer Healthcare. Earlier in his career, he spent nearly five years at Cadbury, handling roles across shopper and customer marketing, as well as branch sales.
Announcing his appointment on LinkedIn, Kaul expressed enthusiasm about leading Cipla Health into its next phase of growth. Reflecting on his previous role, he highlighted the achievements of the India business and the collective contribution of its teams. He also pointed to the evolving consumer health and wellness landscape in India as an opportunity to build trusted brands, drive innovation and make everyday healthcare more accessible.
Kaul added that he looks forward to working with colleagues and partners to create a meaningful impact on people's lives, reaffirming the company's commitment to its purpose of caring for life.
